Skip to main content
Top
Published in: Breast Cancer 1/2019

01-01-2019 | Review Article

Axillary reverse mapping (ARM): where to go

Authors: Xuan Shao, Bo Sun, Yanwen Shen

Published in: Breast Cancer | Issue 1/2019

Login to get access

Abstract

In the past decades, breast surgeons have changed the clinical practice in the surgical treatment of breast cancer, by performing sentinel lymph node biopsy (SLNB) instead of performing axillary lymph node dissection (ALND) in axillary lymph node clinically negative breast cancer patients. ALND can also be avoided in SLN-positive patients who meet the Z-0011 criteria. However, the postoperative complications of SLNB and ALND, such as the secondary upper extremity lymphedema, are common and need effective solutions to prevent as soon as possible. The axillary reverse mapping (ARM) technique has been developed to map and preserve arm lymphatic drainage during ALND and/or SLNB, thereby minimizing arm lymphedema. However, the success of ARM in reducing lymphedema has not been exactly determined. If ARM can be confirmed to be both effective and oncologically safe in preventing lymphedema, this technique should be recommended in the management of breast cancer treatment.
Literature
1.
go back to reference Siegel RL, Miller KD, Jemal A. Cancer statistics 2017. CA Cancer J Clin. 2017;67(1):7–30. (PubMed PMID: 28055103. Epub 2017/01/06. eng).CrossRefPubMed Siegel RL, Miller KD, Jemal A. Cancer statistics 2017. CA Cancer J Clin. 2017;67(1):7–30. (PubMed PMID: 28055103. Epub 2017/01/06. eng).CrossRefPubMed
2.
go back to reference Early Breast Cancer Trialists’ Collaborative G. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687–717. (PubMed PMID: 15894097).CrossRef Early Breast Cancer Trialists’ Collaborative G. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687–717. (PubMed PMID: 15894097).CrossRef
3.
go back to reference Kinoshita I, Fukami A, Nishi M, Kuno K, Kajitani T. An extended radical operation for breast cancer. Shujutsu Oper. 1969;23(3):281–90. (PubMed PMID: 5805593. Epub 1969/03/01.jpn). Kinoshita I, Fukami A, Nishi M, Kuno K, Kajitani T. An extended radical operation for breast cancer. Shujutsu Oper. 1969;23(3):281–90. (PubMed PMID: 5805593. Epub 1969/03/01.jpn).
4.
go back to reference Patey DH, Dyson WH. The prognosis of carcinoma of the breast in relation to the type of operation performed. Br J Cancer. 1948;2(1):7–13. (PubMed PMID: 18863724. Pubmed Central PMCID: 2007539).CrossRefPubMedPubMedCentral Patey DH, Dyson WH. The prognosis of carcinoma of the breast in relation to the type of operation performed. Br J Cancer. 1948;2(1):7–13. (PubMed PMID: 18863724. Pubmed Central PMCID: 2007539).CrossRefPubMedPubMedCentral
5.
go back to reference Giuliano AE, Hawes D, Ballman KV, Whitworth PW, Blumencranz PW, Reintgen DS, et al. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. Jama. 2011;306(4):385–93. (PubMed PMID: 21791687. Epub 2011/07/28. eng).CrossRefPubMedPubMedCentral Giuliano AE, Hawes D, Ballman KV, Whitworth PW, Blumencranz PW, Reintgen DS, et al. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. Jama. 2011;306(4):385–93. (PubMed PMID: 21791687. Epub 2011/07/28. eng).CrossRefPubMedPubMedCentral
6.
go back to reference Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981–22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303–10. (PubMed PMID: 25439688. Pubmed Central PMCID: PMC4291166. Epub 2014/12/03. eng).CrossRefPubMedPubMedCentral Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981–22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303–10. (PubMed PMID: 25439688. Pubmed Central PMCID: PMC4291166. Epub 2014/12/03. eng).CrossRefPubMedPubMedCentral
7.
go back to reference Ahmed M, Rubio IT, Kovacs T, Klimberg VS, Douek M. Systematic review of axillary reverse mapping in breast cancer. Br J Surg. 2016;103(3):170–8. (PubMed PMID: 26661686. Epub 2015/12/15. eng).CrossRefPubMed Ahmed M, Rubio IT, Kovacs T, Klimberg VS, Douek M. Systematic review of axillary reverse mapping in breast cancer. Br J Surg. 2016;103(3):170–8. (PubMed PMID: 26661686. Epub 2015/12/15. eng).CrossRefPubMed
8.
go back to reference Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007;25(24):3657–63. (PubMed PMID: 17485711. Epub 2007/05/09. eng).CrossRefPubMed Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007;25(24):3657–63. (PubMed PMID: 17485711. Epub 2007/05/09. eng).CrossRefPubMed
9.
10.
go back to reference Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer (Oxford, England: 1990). 1992;28a(8–9):1415–8. (PubMed PMID: 1515262. Epub 1992/01/01. eng).CrossRef Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer (Oxford, England: 1990). 1992;28a(8–9):1415–8. (PubMed PMID: 1515262. Epub 1992/01/01. eng).CrossRef
11.
go back to reference Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival—a Bayesian meta-analysis. Ann Surg Oncol. 1999;6(1):109–16. (PubMed PMID: 10030423. Epub 1999/02/25. eng).CrossRefPubMed Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival—a Bayesian meta-analysis. Ann Surg Oncol. 1999;6(1):109–16. (PubMed PMID: 10030423. Epub 1999/02/25. eng).CrossRefPubMed
12.
go back to reference Krag DN, Single RM. Breast cancer survival according to number of nodes removed. Ann Surg Oncol. 2003;10(10):1152–9. (PubMed PMID: 14654470. Epub 2003/12/05. eng).CrossRefPubMed Krag DN, Single RM. Breast cancer survival according to number of nodes removed. Ann Surg Oncol. 2003;10(10):1152–9. (PubMed PMID: 14654470. Epub 2003/12/05. eng).CrossRefPubMed
13.
go back to reference Noguchi M, Miwa K, Michigishi T, Yokoyama K, Nishijima H, Takanaka T, et al. The role of axillary lymph node dissection in breast cancer management. Breast Cancer (Tokyo, Japan). 1997;4(3):143–53. (PubMed PMID: 11091589. Epub 2000/11/25. eng).CrossRef Noguchi M, Miwa K, Michigishi T, Yokoyama K, Nishijima H, Takanaka T, et al. The role of axillary lymph node dissection in breast cancer management. Breast Cancer (Tokyo, Japan). 1997;4(3):143–53. (PubMed PMID: 11091589. Epub 2000/11/25. eng).CrossRef
14.
go back to reference Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98(9):599–609. (PubMed PMID: 16670385. Epub 2006/05/04. eng).CrossRefPubMed Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98(9):599–609. (PubMed PMID: 16670385. Epub 2006/05/04. eng).CrossRefPubMed
15.
go back to reference Leidenius M, Leivonen M, Vironen J, von Smitten K. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol. 2005;92(1):23–31. (PubMed PMID: 16180231. Epub 2005/09/24. eng).CrossRefPubMed Leidenius M, Leivonen M, Vironen J, von Smitten K. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol. 2005;92(1):23–31. (PubMed PMID: 16180231. Epub 2005/09/24. eng).CrossRefPubMed
16.
go back to reference Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol. 2002;9(8):745–53. (PubMed PMID: 12374657. Epub 2002/10/11. eng).CrossRefPubMed Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol. 2002;9(8):745–53. (PubMed PMID: 12374657. Epub 2002/10/11. eng).CrossRefPubMed
17.
go back to reference Tanis PJ, Nieweg OE, Valdes Olmos RA, Th Rutgers EJ, Kroon BB. History of sentinel node and validation of the technique. Breast Cancer Res BCR. 2001;3(2):109–12. (PubMed PMID: 11250756. Pubmed Central PMCID: Pmc139441. Epub 2001/03/16. eng).CrossRefPubMed Tanis PJ, Nieweg OE, Valdes Olmos RA, Th Rutgers EJ, Kroon BB. History of sentinel node and validation of the technique. Breast Cancer Res BCR. 2001;3(2):109–12. (PubMed PMID: 11250756. Pubmed Central PMCID: Pmc139441. Epub 2001/03/16. eng).CrossRefPubMed
18.
go back to reference Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg (Chicago, Ill: 1960). 1992;127(4):392–9. (PubMed PMID: 1558490. Epub 1992/04/01. eng).CrossRef Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg (Chicago, Ill: 1960). 1992;127(4):392–9. (PubMed PMID: 1558490. Epub 1992/04/01. eng).CrossRef
19.
go back to reference Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220(3):391–8. (discussion 8–401. PubMed PMID: 8092905. Pubmed Central PMCID: 1234400).CrossRefPubMedPubMedCentral Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220(3):391–8. (discussion 8–401. PubMed PMID: 8092905. Pubmed Central PMCID: 1234400).CrossRefPubMedPubMedCentral
20.
go back to reference Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet. 1981;152(6):765–72. (PubMed PMID: 7244951. Epub 1981/06/01. eng).PubMed Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet. 1981;152(6):765–72. (PubMed PMID: 7244951. Epub 1981/06/01. eng).PubMed
21.
go back to reference Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347(8):567–75. (PubMed PMID: 12192016. Epub 2002/08/23. eng).CrossRefPubMed Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347(8):567–75. (PubMed PMID: 12192016. Epub 2002/08/23. eng).CrossRefPubMed
22.
go back to reference Louis-Sylvestre C, Clough K, Asselain B, Vilcoq JR, Salmon RJ, Campana F, et al. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol. 2004;22(1):97–101. (PubMed PMID: 14701770. Epub 2004/01/01. eng).CrossRefPubMed Louis-Sylvestre C, Clough K, Asselain B, Vilcoq JR, Salmon RJ, Campana F, et al. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol. 2004;22(1):97–101. (PubMed PMID: 14701770. Epub 2004/01/01. eng).CrossRefPubMed
23.
go back to reference Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927–33. (PubMed PMID: 20863759. Pubmed Central PMCID: Pmc3041644. Epub 2010/09/25. eng).CrossRefPubMedPubMedCentral Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927–33. (PubMed PMID: 20863759. Pubmed Central PMCID: Pmc3041644. Epub 2010/09/25. eng).CrossRefPubMedPubMedCentral
24.
go back to reference Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23(30):7703–20. (PubMed PMID: 16157938. Epub 2005/09/15. eng).CrossRefPubMed Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23(30):7703–20. (PubMed PMID: 16157938. Epub 2005/09/15. eng).CrossRefPubMed
25.
go back to reference Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14(4):297–305. (PubMed PMID: 23491275. Pubmed Central PMCID: Pmc3935346. Epub 2013/03/16. eng).CrossRefPubMedPubMedCentral Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14(4):297–305. (PubMed PMID: 23491275. Pubmed Central PMCID: Pmc3935346. Epub 2013/03/16. eng).CrossRefPubMedPubMedCentral
26.
go back to reference Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ. Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22(8):1736–47. (PubMed PMID: 21709140. Pubmed Central PMCID: Pmc3144634. Epub 2011/06/29. eng).CrossRefPubMedPubMedCentral Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ. Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22(8):1736–47. (PubMed PMID: 21709140. Pubmed Central PMCID: Pmc3144634. Epub 2011/06/29. eng).CrossRefPubMedPubMedCentral
27.
go back to reference Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252(3):426–32. (discussion 32–3. PubMed PMID: 20739842. Epub 2010/08/27. eng).PubMed Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252(3):426–32. (discussion 32–3. PubMed PMID: 20739842. Epub 2010/08/27. eng).PubMed
28.
go back to reference Straver ME, Meijnen P, van Tienhoven G, van de Velde CJ, Mansel RE, Bogaerts J, et al. Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J Clin Oncol. 2010;28(5):731–7. (PubMed PMID: 20038733. Pubmed Central PMCID: 2834391).CrossRefPubMed Straver ME, Meijnen P, van Tienhoven G, van de Velde CJ, Mansel RE, Bogaerts J, et al. Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J Clin Oncol. 2010;28(5):731–7. (PubMed PMID: 20038733. Pubmed Central PMCID: 2834391).CrossRefPubMed
29.
go back to reference Savolt A, Musonda P, Matrai Z, Polgar C, Renyi-Vamos F, Rubovszky G, et al. Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial. Orvosi hetilap. 2013;154(49):1934–42. (PubMed PMID: 24292111. Epub 2013/12/03. Az axilla optimalis kezelese pozitiv orszemnyirokcsomo eseten korai invaziv emlorakban. Az OTOASOR vizsgalat elozetes eredmenyei. hun).CrossRefPubMed Savolt A, Musonda P, Matrai Z, Polgar C, Renyi-Vamos F, Rubovszky G, et al. Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial. Orvosi hetilap. 2013;154(49):1934–42. (PubMed PMID: 24292111. Epub 2013/12/03. Az axilla optimalis kezelese pozitiv orszemnyirokcsomo eseten korai invaziv emlorakban. Az OTOASOR vizsgalat elozetes eredmenyei. hun).CrossRefPubMed
30.
go back to reference Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2014;32(13):1365–83. (PubMed PMID: 24663048. Epub 2014/03/26. eng).CrossRefPubMed Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2014;32(13):1365–83. (PubMed PMID: 24663048. Epub 2014/03/26. eng).CrossRefPubMed
31.
go back to reference Gebruers N, Verbelen H, De Vrieze T, Coeck D, Tjalma W. The incidence and time path of lymphedema in sentinel negative breast cancer patients: a systematic review. Arch Phys Med Rehabil. 2015;96:1131–1139. (PubMed PMID: 25637862. Epub 2015/02/01. Eng).CrossRefPubMed Gebruers N, Verbelen H, De Vrieze T, Coeck D, Tjalma W. The incidence and time path of lymphedema in sentinel negative breast cancer patients: a systematic review. Arch Phys Med Rehabil. 2015;96:1131–1139. (PubMed PMID: 25637862. Epub 2015/02/01. Eng).CrossRefPubMed
32.
go back to reference Noguchi M. Z-11 trial and rethinking axillary reverse mapping. Breast Cancer. 2015;22(2):99–100. (PubMed PMID: 25577513. Epub 2015/01/13. eng).CrossRefPubMed Noguchi M. Z-11 trial and rethinking axillary reverse mapping. Breast Cancer. 2015;22(2):99–100. (PubMed PMID: 25577513. Epub 2015/01/13. eng).CrossRefPubMed
33.
go back to reference Suami H, Taylor GI, Pan WR. The lymphatic territories of the upper limb: anatomical study and clinical implications. Plastic Reconstr Surg. 2007;119(6):1813–22. (PubMed PMID: 17440362. Epub 2007/04/19. eng).CrossRef Suami H, Taylor GI, Pan WR. The lymphatic territories of the upper limb: anatomical study and clinical implications. Plastic Reconstr Surg. 2007;119(6):1813–22. (PubMed PMID: 17440362. Epub 2007/04/19. eng).CrossRef
34.
go back to reference Hama Y, Koyama Y, Urano Y, Choyke PL, Kobayashi H. Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremity. Breast Cancer Res Treat. 2007;103(1):23–8. (PubMed PMID: 17028977. Epub 2006/10/10. eng).CrossRefPubMed Hama Y, Koyama Y, Urano Y, Choyke PL, Kobayashi H. Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremity. Breast Cancer Res Treat. 2007;103(1):23–8. (PubMed PMID: 17028977. Epub 2006/10/10. eng).CrossRefPubMed
35.
go back to reference Thompson M, Korourian S, Henry-Tillman R, Adkins L, Mumford S, Westbrook KC, et al. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Oncol. 2007;14(6):1890–5. (PubMed PMID: 17479341. Epub 2007/05/05. eng).CrossRefPubMed Thompson M, Korourian S, Henry-Tillman R, Adkins L, Mumford S, Westbrook KC, et al. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Oncol. 2007;14(6):1890–5. (PubMed PMID: 17479341. Epub 2007/05/05. eng).CrossRefPubMed
36.
go back to reference Boneti C, Korourian S, Diaz Z, Santiago C, Mumford S, Adkins L, et al. Scientific Impact Award: axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy. Am J Surg. 2009;198(4):482–7. (PubMed PMID: 19800452. Epub 2009/10/06. eng).CrossRefPubMed Boneti C, Korourian S, Diaz Z, Santiago C, Mumford S, Adkins L, et al. Scientific Impact Award: axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy. Am J Surg. 2009;198(4):482–7. (PubMed PMID: 19800452. Epub 2009/10/06. eng).CrossRefPubMed
37.
go back to reference Nos C, Lesieur B, Clough KB, Lecuru F. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection. Ann Surg Oncol. 2007;14(9):2490–6. (PubMed PMID: 17549570. Epub 2007/06/06. eng).CrossRefPubMed Nos C, Lesieur B, Clough KB, Lecuru F. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection. Ann Surg Oncol. 2007;14(9):2490–6. (PubMed PMID: 17549570. Epub 2007/06/06. eng).CrossRefPubMed
38.
go back to reference Boneti C, Korourian S, Bland K, Cox K, Adkins LL, Henry-Tillman RS, et al. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. J Am Coll Surg. 2008;206(5):1038–42. (discussion 42–4. PubMed PMID: 18471751. Epub 2008/05/13. eng).CrossRefPubMed Boneti C, Korourian S, Bland K, Cox K, Adkins LL, Henry-Tillman RS, et al. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. J Am Coll Surg. 2008;206(5):1038–42. (discussion 42–4. PubMed PMID: 18471751. Epub 2008/05/13. eng).CrossRefPubMed
39.
go back to reference Casabona F, Bogliolo S, Valenzano Menada M, Sala P, Villa G, Ferrero S. Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients. Ann Surg Oncol. 2009;16(9):2459–63. (PubMed PMID: 19506954. Epub 2009/06/10. eng).CrossRefPubMed Casabona F, Bogliolo S, Valenzano Menada M, Sala P, Villa G, Ferrero S. Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients. Ann Surg Oncol. 2009;16(9):2459–63. (PubMed PMID: 19506954. Epub 2009/06/10. eng).CrossRefPubMed
40.
go back to reference Han JW, Seo YJ, Choi JE, Kang SH, Bae YK, Lee SJ. The efficacy of arm node preserving surgery using axillary reverse mapping for preventing lymphedema in patients with breast cancer. J Breast Cancer. 2012;15(1):91–7. (PubMed PMID: 22493634. Pubmed Central PMCID: Pmc3318181. Epub 2012/04/12. eng).CrossRefPubMedPubMedCentral Han JW, Seo YJ, Choi JE, Kang SH, Bae YK, Lee SJ. The efficacy of arm node preserving surgery using axillary reverse mapping for preventing lymphedema in patients with breast cancer. J Breast Cancer. 2012;15(1):91–7. (PubMed PMID: 22493634. Pubmed Central PMCID: Pmc3318181. Epub 2012/04/12. eng).CrossRefPubMedPubMedCentral
41.
go back to reference Beek MA, Gobardhan PD, Klompenhouwer EG, Rutten HJ, Voogd AC, Luiten EJ. Axillary reverse mapping (ARM) in clinically node positive breast cancer patients. Eur J Surg Oncol. 2015;41(1):59–63. (PubMed PMID: 25468747. Epub 2014/12/04. eng).CrossRefPubMed Beek MA, Gobardhan PD, Klompenhouwer EG, Rutten HJ, Voogd AC, Luiten EJ. Axillary reverse mapping (ARM) in clinically node positive breast cancer patients. Eur J Surg Oncol. 2015;41(1):59–63. (PubMed PMID: 25468747. Epub 2014/12/04. eng).CrossRefPubMed
42.
go back to reference Deng H, Chen L, Jia W, Chen K, Zeng Y, Rao N, et al. Safety study of axillary reverse mapping in the surgical treatment for breast cancer patients. J Cancer Res Clin Oncol. 2011;137(12):1869–74. (PubMed PMID: 21935615. Epub 2011/09/22. eng).CrossRefPubMed Deng H, Chen L, Jia W, Chen K, Zeng Y, Rao N, et al. Safety study of axillary reverse mapping in the surgical treatment for breast cancer patients. J Cancer Res Clin Oncol. 2011;137(12):1869–74. (PubMed PMID: 21935615. Epub 2011/09/22. eng).CrossRefPubMed
43.
go back to reference Bedrosian I, Babiera GV, Mittendorf EA, Kuerer HM, Pantoja L, Hunt KK, et al. A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer. 2010;116(11):2543–8. (PubMed PMID: 20336790. Epub 2010/03/26. eng).PubMed Bedrosian I, Babiera GV, Mittendorf EA, Kuerer HM, Pantoja L, Hunt KK, et al. A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer. 2010;116(11):2543–8. (PubMed PMID: 20336790. Epub 2010/03/26. eng).PubMed
44.
go back to reference Ochoa D, Korourian S, Boneti C, Adkins L, Badgwell B, Klimberg VS. Axillary reverse mapping: five-year experience. Surgery. 2014;156(5):1261–8. (PubMed PMID: 25444319. Epub 2014/12/03. eng).CrossRefPubMed Ochoa D, Korourian S, Boneti C, Adkins L, Badgwell B, Klimberg VS. Axillary reverse mapping: five-year experience. Surgery. 2014;156(5):1261–8. (PubMed PMID: 25444319. Epub 2014/12/03. eng).CrossRefPubMed
45.
go back to reference Boccardo F, Casabona F, De Cian F, Friedman D, Villa G, Bogliolo S, et al. Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol. 2009;16(3):703–8. (PubMed PMID: 19139964. Epub 2009/01/14. eng).CrossRefPubMed Boccardo F, Casabona F, De Cian F, Friedman D, Villa G, Bogliolo S, et al. Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol. 2009;16(3):703–8. (PubMed PMID: 19139964. Epub 2009/01/14. eng).CrossRefPubMed
46.
go back to reference Ponzone R, Cont NT, Maggiorotto F, Cassina E, Mininanni P, Biglia N, et al. Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer. J Clin Oncol. 2009;27(33):5547–51. (PubMed PMID: 19826123. Epub 2009/10/15. eng).CrossRefPubMed Ponzone R, Cont NT, Maggiorotto F, Cassina E, Mininanni P, Biglia N, et al. Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer. J Clin Oncol. 2009;27(33):5547–51. (PubMed PMID: 19826123. Epub 2009/10/15. eng).CrossRefPubMed
47.
go back to reference Gobardhan PD, Wijsman JH, van Dalen T, Klompenhouwer EG, van der Schelling GP, Los J, et al. ARM: axillary reverse mapping—the need for selection of patients. Eur J Surg Oncol. 2012;38(8):657–61. (PubMed PMID: 22607749. Epub 2012/05/23. eng).CrossRefPubMed Gobardhan PD, Wijsman JH, van Dalen T, Klompenhouwer EG, van der Schelling GP, Los J, et al. ARM: axillary reverse mapping—the need for selection of patients. Eur J Surg Oncol. 2012;38(8):657–61. (PubMed PMID: 22607749. Epub 2012/05/23. eng).CrossRefPubMed
48.
go back to reference Schunemann E Jr, Doria MT, Silvestre JB, Gasperin P Jr, Cavalcanti TC, Budel VM. Prospective study evaluating oncological safety of axillary reverse mapping. Ann Surg Oncol. 2014;21(7):2197–202. (PubMed PMID: 24599413. Pubmed Central PMCID: Pmc4047480. Epub 2014/03/07. eng).CrossRefPubMedPubMedCentral Schunemann E Jr, Doria MT, Silvestre JB, Gasperin P Jr, Cavalcanti TC, Budel VM. Prospective study evaluating oncological safety of axillary reverse mapping. Ann Surg Oncol. 2014;21(7):2197–202. (PubMed PMID: 24599413. Pubmed Central PMCID: Pmc4047480. Epub 2014/03/07. eng).CrossRefPubMedPubMedCentral
49.
go back to reference Tausch C, Baege A, Dietrich D, Vergin I, Heuer H, Heusler RH, et al. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients? Eur J Surg Oncol. 2013;39(8):880–6. (PubMed PMID: 23735162. Epub 2013/06/06. eng).CrossRefPubMed Tausch C, Baege A, Dietrich D, Vergin I, Heuer H, Heusler RH, et al. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients? Eur J Surg Oncol. 2013;39(8):880–6. (PubMed PMID: 23735162. Epub 2013/06/06. eng).CrossRefPubMed
50.
go back to reference Britton TB, Solanki CK, Pinder SE, Mortimer PS, Peters AM, Purushotham AD. Lymphatic drainage pathways of the breast and the upper limb. Nucl Med Commun. 2009;30(6):427–30. (PubMed PMID: 19319006. Epub 2009/03/26. eng).CrossRefPubMed Britton TB, Solanki CK, Pinder SE, Mortimer PS, Peters AM, Purushotham AD. Lymphatic drainage pathways of the breast and the upper limb. Nucl Med Commun. 2009;30(6):427–30. (PubMed PMID: 19319006. Epub 2009/03/26. eng).CrossRefPubMed
51.
go back to reference Gennaro M, Maccauro M, Sigari C, Casalini P, Bedodi L, Conti AR, et al. Selective axillary dissection after axillary reverse mapping to prevent breast-cancer-related lymphoedema. Eur J Surg Oncol. 2013;39(12):1341–5. (PubMed PMID: 24113621. Epub 2013/10/12. eng).CrossRefPubMed Gennaro M, Maccauro M, Sigari C, Casalini P, Bedodi L, Conti AR, et al. Selective axillary dissection after axillary reverse mapping to prevent breast-cancer-related lymphoedema. Eur J Surg Oncol. 2013;39(12):1341–5. (PubMed PMID: 24113621. Epub 2013/10/12. eng).CrossRefPubMed
52.
go back to reference Yue T, Zhuang D, Zhou P, Zheng L, Fan Z, Zhu J, et al. A prospective study to assess the feasibility of axillary reverse mapping and evaluate its effect on preventing lymphedema in breast cancer patients. Clin Breast Cancer. 2015;15(4):301–6. (PubMed PMID: 25776198. Epub 2015/03/18. eng).CrossRefPubMed Yue T, Zhuang D, Zhou P, Zheng L, Fan Z, Zhu J, et al. A prospective study to assess the feasibility of axillary reverse mapping and evaluate its effect on preventing lymphedema in breast cancer patients. Clin Breast Cancer. 2015;15(4):301–6. (PubMed PMID: 25776198. Epub 2015/03/18. eng).CrossRefPubMed
53.
go back to reference Nos C, Kaufmann G, Clough KB, Collignon MA, Zerbib E, Cusumano P, et al. Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection. Ann Surg Oncol. 2008;15(9):2550–5. (PubMed PMID: 18618185. Epub 2008/07/12. eng).CrossRefPubMed Nos C, Kaufmann G, Clough KB, Collignon MA, Zerbib E, Cusumano P, et al. Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection. Ann Surg Oncol. 2008;15(9):2550–5. (PubMed PMID: 18618185. Epub 2008/07/12. eng).CrossRefPubMed
54.
go back to reference Noguchi M, Inokuchi M, Zen Y. Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy. J Surg Oncol. 2009;100(2):100–5. (PubMed PMID: 19479943. Epub 2009/05/30. eng).CrossRefPubMed Noguchi M, Inokuchi M, Zen Y. Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy. J Surg Oncol. 2009;100(2):100–5. (PubMed PMID: 19479943. Epub 2009/05/30. eng).CrossRefPubMed
55.
go back to reference Sakurai T, Endo M, Shimizu K, Yoshimizu N, Nakajima K, Nosaka K, et al. Axillary reverse mapping using fluorescence imaging is useful for identifying the risk group of postoperative lymphedema in breast cancer patients undergoing sentinel node biopsies. J Surg Oncol. 2014;109(6):612–5. (PubMed PMID: 24310418. Pubmed Central PMCID: Pmc4263257. Epub 2013/12/07. eng).CrossRefPubMed Sakurai T, Endo M, Shimizu K, Yoshimizu N, Nakajima K, Nosaka K, et al. Axillary reverse mapping using fluorescence imaging is useful for identifying the risk group of postoperative lymphedema in breast cancer patients undergoing sentinel node biopsies. J Surg Oncol. 2014;109(6):612–5. (PubMed PMID: 24310418. Pubmed Central PMCID: Pmc4263257. Epub 2013/12/07. eng).CrossRefPubMed
56.
go back to reference Noguchi M, Noguchi M, Nakano Y, Ohno Y, Kosaka T. Axillary reverse mapping using a fluorescence imaging system in breast cancer. J Surg Oncol. 2012;105(3):229–34. (PubMed PMID: 21913193. Epub 2011/09/14. eng).CrossRefPubMed Noguchi M, Noguchi M, Nakano Y, Ohno Y, Kosaka T. Axillary reverse mapping using a fluorescence imaging system in breast cancer. J Surg Oncol. 2012;105(3):229–34. (PubMed PMID: 21913193. Epub 2011/09/14. eng).CrossRefPubMed
57.
go back to reference Ikeda K, Ogawa Y, Kajino C, Deguchi S, Kurihara S, Tashima T, et al. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients. Eur J Surg Oncol. 2014;40(7):818–23. (PubMed PMID: 24768416. Epub 2014/04/29. eng).CrossRefPubMed Ikeda K, Ogawa Y, Kajino C, Deguchi S, Kurihara S, Tashima T, et al. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients. Eur J Surg Oncol. 2014;40(7):818–23. (PubMed PMID: 24768416. Epub 2014/04/29. eng).CrossRefPubMed
58.
go back to reference Noguchi M, Yokoi M, Nakano Y. Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer. J Surg Oncol. 2010;101(3):217–21. (PubMed PMID: 20063370. Epub 2010/01/12. eng).PubMed Noguchi M, Yokoi M, Nakano Y. Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer. J Surg Oncol. 2010;101(3):217–21. (PubMed PMID: 20063370. Epub 2010/01/12. eng).PubMed
59.
go back to reference Ikeda K, Ogawa Y, Komatsu H, Mori Y, Ishikawa A, Nakajima T, et al. Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients. World J Surg Oncol. 2012;10:233. (PubMed PMID: 23116152. Pubmed Central PMCID: Pmc3527301. Epub 2012/11/03. eng).CrossRefPubMedPubMedCentral Ikeda K, Ogawa Y, Komatsu H, Mori Y, Ishikawa A, Nakajima T, et al. Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients. World J Surg Oncol. 2012;10:233. (PubMed PMID: 23116152. Pubmed Central PMCID: Pmc3527301. Epub 2012/11/03. eng).CrossRefPubMedPubMedCentral
60.
go back to reference Ponzone R, Mininanni P, Cassina E, Sismondi P. Axillary reverse mapping in breast cancer: can we spare what we find? Ann Surg Oncol. 2008;15(1):390–1. (author reply 2–3. PubMed PMID: 17990039. Epub 2007/11/09. eng).CrossRefPubMed Ponzone R, Mininanni P, Cassina E, Sismondi P. Axillary reverse mapping in breast cancer: can we spare what we find? Ann Surg Oncol. 2008;15(1):390–1. (author reply 2–3. PubMed PMID: 17990039. Epub 2007/11/09. eng).CrossRefPubMed
61.
go back to reference Kuusk U, Seyednejad N, McKevitt EC, Dingee CK, Wiseman SM. Axillary reverse mapping in breast cancer: a Canadian experience. J Surg Oncol. 2014;110(7):791–5. (PubMed PMID: 25053441. Epub 2014/07/24. eng).CrossRefPubMed Kuusk U, Seyednejad N, McKevitt EC, Dingee CK, Wiseman SM. Axillary reverse mapping in breast cancer: a Canadian experience. J Surg Oncol. 2014;110(7):791–5. (PubMed PMID: 25053441. Epub 2014/07/24. eng).CrossRefPubMed
62.
go back to reference Rubio IT, Cebrecos I, Peg V, Esgueva A, Mendoza C, Cortadellas T, et al. Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer. J Surg Oncol. 2012;106(1):89–93. (PubMed PMID: 22258666. Epub 2012/01/20. eng).CrossRefPubMed Rubio IT, Cebrecos I, Peg V, Esgueva A, Mendoza C, Cortadellas T, et al. Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer. J Surg Oncol. 2012;106(1):89–93. (PubMed PMID: 22258666. Epub 2012/01/20. eng).CrossRefPubMed
63.
go back to reference Yue T, Zhuang D, Zhou P, Zheng L, Fan Z, Zhu J, et al. A prospective study to assess the feasibility of axillary reverse mapping and evaluate its effect on preventing lymphedema in breast cancer patients. Clin Breast Cancer. 2015;15:301–6. (PubMed PMID: 25776198. Epub 2015/03/18. Eng).CrossRefPubMed Yue T, Zhuang D, Zhou P, Zheng L, Fan Z, Zhu J, et al. A prospective study to assess the feasibility of axillary reverse mapping and evaluate its effect on preventing lymphedema in breast cancer patients. Clin Breast Cancer. 2015;15:301–6. (PubMed PMID: 25776198. Epub 2015/03/18. Eng).CrossRefPubMed
64.
go back to reference Klompenhouwer EG, Gobardhan PD, Beek MA, Voogd AC, Luiten EJ. The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial. Trials. 2013;14:111. (PubMed PMID: 23782712. Pubmed Central PMCID: PMC3663653. Epub 2013/06/21. eng).CrossRefPubMedPubMedCentral Klompenhouwer EG, Gobardhan PD, Beek MA, Voogd AC, Luiten EJ. The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial. Trials. 2013;14:111. (PubMed PMID: 23782712. Pubmed Central PMCID: PMC3663653. Epub 2013/06/21. eng).CrossRefPubMedPubMedCentral
65.
go back to reference Pavlista D, Eliska O. Relationship between the lymphatic drainage of the breast and the upper extremity: a postmortem study. Ann Surg Oncol. 2012;19(11):3410–5. (PubMed PMID: 22526910. Epub 2012/04/25. eng).CrossRefPubMed Pavlista D, Eliska O. Relationship between the lymphatic drainage of the breast and the upper extremity: a postmortem study. Ann Surg Oncol. 2012;19(11):3410–5. (PubMed PMID: 22526910. Epub 2012/04/25. eng).CrossRefPubMed
66.
go back to reference Pavlista D, Eliska O. Analysis of direct oil contrast lymphography of upper limb lymphatics traversing the axilla—a lesson from the past—contribution to the concept of axillary reverse mapping. Eur J Surg Oncol. 2012;38(5):390–4. (PubMed PMID: 22336143. Epub 2012/02/18. eng).CrossRefPubMed Pavlista D, Eliska O. Analysis of direct oil contrast lymphography of upper limb lymphatics traversing the axilla—a lesson from the past—contribution to the concept of axillary reverse mapping. Eur J Surg Oncol. 2012;38(5):390–4. (PubMed PMID: 22336143. Epub 2012/02/18. eng).CrossRefPubMed
67.
go back to reference Pavlista D, Koliba P, Eliska O. Axillary reverse mapping—chance to prevent lymphedema in breast cancer patients. Ceska gynekologie/Ceska lekarska spolecnost. J Ev Purkyne. 2011;76(5):355–9. (PubMed PMID: 22132635. Epub 2011/12/03. Reverzni mapovani lymfatik v axile jako moznost prevence lymfedemu u pacientek s karcinomem prsu. cze). Pavlista D, Koliba P, Eliska O. Axillary reverse mapping—chance to prevent lymphedema in breast cancer patients. Ceska gynekologie/Ceska lekarska spolecnost. J Ev Purkyne. 2011;76(5):355–9. (PubMed PMID: 22132635. Epub 2011/12/03. Reverzni mapovani lymfatik v axile jako moznost prevence lymfedemu u pacientek s karcinomem prsu. cze).
68.
go back to reference Suami H, O’Neill JK, Pan WR, Taylor GI. Superficial lymphatic system of the upper torso: preliminary radiographic results in human cadavers. Plastic Reconstr Surg. 2008;121(4):1231–9. (PubMed PMID: 18349641. Epub 2008/03/20. eng).CrossRef Suami H, O’Neill JK, Pan WR, Taylor GI. Superficial lymphatic system of the upper torso: preliminary radiographic results in human cadavers. Plastic Reconstr Surg. 2008;121(4):1231–9. (PubMed PMID: 18349641. Epub 2008/03/20. eng).CrossRef
69.
go back to reference Senofsky GM, Moffat FL Jr, Davis K, Masri MM, Clark KC, Robinson DS, et al. Total axillary lymphadenectomy in the management of breast cancer. Archives of surgery (Chicago, Ill: 1960). 1991;126(11):1336–41. (discussion 41–2. PubMed PMID: 1747046. Epub 1991/11/11. eng). Senofsky GM, Moffat FL Jr, Davis K, Masri MM, Clark KC, Robinson DS, et al. Total axillary lymphadenectomy in the management of breast cancer. Archives of surgery (Chicago, Ill: 1960). 1991;126(11):1336–41. (discussion 41–2. PubMed PMID: 1747046. Epub 1991/11/11. eng).
70.
go back to reference Mihara M, Hayashi Y, Hara H, Todokoro T, Koshima I, Murai N. Lymphatic-venous anastomosis for the radical cure of a large pelvic lymphocyst. J Minim Invasive Gynecol. 2012;19(1):125–7. (PubMed PMID: 22196262. Epub 2011/12/27. eng).CrossRefPubMed Mihara M, Hayashi Y, Hara H, Todokoro T, Koshima I, Murai N. Lymphatic-venous anastomosis for the radical cure of a large pelvic lymphocyst. J Minim Invasive Gynecol. 2012;19(1):125–7. (PubMed PMID: 22196262. Epub 2011/12/27. eng).CrossRefPubMed
71.
go back to reference Campisi C, Bellini C, Campisi C, Accogli S, Bonioli E, Boccardo F. Microsurgery for lymphedema: clinical research and long-term results. Microsurgery. 2010;30(4):256–60. (PubMed PMID: 20235160. Epub 2010/03/18. eng).PubMed Campisi C, Bellini C, Campisi C, Accogli S, Bonioli E, Boccardo F. Microsurgery for lymphedema: clinical research and long-term results. Microsurgery. 2010;30(4):256–60. (PubMed PMID: 20235160. Epub 2010/03/18. eng).PubMed
72.
go back to reference Campisi C, Boccardo F. Microsurgical techniques for lymphedema treatment: derivative lymphatic-venous microsurgery. World J Surg. 2004;28(6):609–13. (PubMed PMID: 15366754. Epub 2004/09/16. eng).CrossRefPubMed Campisi C, Boccardo F. Microsurgical techniques for lymphedema treatment: derivative lymphatic-venous microsurgery. World J Surg. 2004;28(6):609–13. (PubMed PMID: 15366754. Epub 2004/09/16. eng).CrossRefPubMed
73.
go back to reference Damstra RJ, Voesten HG, van Schelven WD, van der Lei B. Lymphatic venous anastomosis (LVA) for treatment of secondary arm lymphedema. A prospective study of 11 LVA procedures in 10 patients with breast cancer related lymphedema and a critical review of the literature. Breast Cancer Res Treat. 2009;113(2):199–206. (PubMed PMID: 18270813. Epub 2008/02/14. eng).CrossRefPubMed Damstra RJ, Voesten HG, van Schelven WD, van der Lei B. Lymphatic venous anastomosis (LVA) for treatment of secondary arm lymphedema. A prospective study of 11 LVA procedures in 10 patients with breast cancer related lymphedema and a critical review of the literature. Breast Cancer Res Treat. 2009;113(2):199–206. (PubMed PMID: 18270813. Epub 2008/02/14. eng).CrossRefPubMed
74.
go back to reference Noguchi M. Axillary reverse mapping for breast cancer. Breast Cancer Res Treat. 2010;119(3):529–35. (PubMed PMID: 19842033. Epub 2009/10/21. eng).CrossRefPubMed Noguchi M. Axillary reverse mapping for breast cancer. Breast Cancer Res Treat. 2010;119(3):529–35. (PubMed PMID: 19842033. Epub 2009/10/21. eng).CrossRefPubMed
75.
go back to reference DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500–15. (PubMed PMID: 23540561. Epub 2013/04/02. eng).CrossRefPubMed DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500–15. (PubMed PMID: 23540561. Epub 2013/04/02. eng).CrossRefPubMed
76.
go back to reference Jammallo LS, Miller CL, Singer M, Horick NK, Skolny MN, Specht MC, et al. Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer. Breast Cancer Res Treat. 2013;142(1):59–67. (PubMed PMID: 24122390. Pubmed Central PMCID: Pmc3873728. Epub 2013/10/15. eng).CrossRefPubMed Jammallo LS, Miller CL, Singer M, Horick NK, Skolny MN, Specht MC, et al. Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer. Breast Cancer Res Treat. 2013;142(1):59–67. (PubMed PMID: 24122390. Pubmed Central PMCID: Pmc3873728. Epub 2013/10/15. eng).CrossRefPubMed
77.
go back to reference Ugur S, Arici C, Yaprak M, Mesci A, Arici GA, Dolay K, et al. Risk factors of breast cancer-related lymphedema. Lymph Res Biol. 2013;11(2):72–5. (PubMed PMID: 23772716. Pubmed Central PMCID: Pmc3685313. Epub 2013/06/19. eng).CrossRef Ugur S, Arici C, Yaprak M, Mesci A, Arici GA, Dolay K, et al. Risk factors of breast cancer-related lymphedema. Lymph Res Biol. 2013;11(2):72–5. (PubMed PMID: 23772716. Pubmed Central PMCID: Pmc3685313. Epub 2013/06/19. eng).CrossRef
78.
go back to reference Pasko JL, Garreau J, Carl A, Ansteth M, Glissmeyer M, Johnson N. Axillary reverse lymphatic mapping reduces patient perceived incidence of lymphedema after axillary dissection in breast cancer. Am J Surg. 2015;209(5):890–5. (PubMed PMID: 25796096. Epub 2015/03/23. eng).CrossRefPubMed Pasko JL, Garreau J, Carl A, Ansteth M, Glissmeyer M, Johnson N. Axillary reverse lymphatic mapping reduces patient perceived incidence of lymphedema after axillary dissection in breast cancer. Am J Surg. 2015;209(5):890–5. (PubMed PMID: 25796096. Epub 2015/03/23. eng).CrossRefPubMed
Metadata
Title
Axillary reverse mapping (ARM): where to go
Authors
Xuan Shao
Bo Sun
Yanwen Shen
Publication date
01-01-2019
Publisher
Springer Japan
Published in
Breast Cancer / Issue 1/2019
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-018-0886-0

Other articles of this Issue 1/2019

Breast Cancer 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine